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Transfer of T cells into irradiated H-2-incompatible mice is followed 4 days 
later by the appearance of large numbers of donor-derived,  0-positive, blast T 
cells  in thoracic  duct  lymph  (T.TDL)  (1).  Virtually  all  T.TDL  carry  surface 
immunoglobulin (Ig) (2-4). When T.TDL were generated from T-cell populations 
depleted of B cells, the surface Ig on T.TDL was considerably reduced (4). It was 
concluded therefore that at least a proportion of the Ig detected on T.TDL was 
alloantibody  of donor  B-cell  origin  and  might  be  attached  via  soluble  host 
alloantigens bound by antigen-specific receptors. 
Two predictions follow from this hypothesis: first, that T.TDL would be Ig 
negative when raised against determinants which stimulate T cells but not B 
cells, for example, M-locus determinants (5); and second, that T.TDL activated 
to H-2 determinants (though not to M-locus determinants) would adsorb specific 
alloantibody when incubated with appropriate alloantisera in vitro. This paper 
presents data which are in accord with these predictions. 
Materials and Methods 
Cells.  T.TDL were generated against H-2 and M-locus differences by the transfer of thymo- 
cytes between strain combinations as shown in Table I: activated cells were collected by cannula- 
tion of the thoracic duct (1) at 4 or 5 days later. In some experiments thymocytes were depleted of 
Ig-bearing (B) cells by anti-Ig column filtration (6). 
Antisera 
ANTI-Ig. SERA.  Antisera were raised in rabbits against mouse Ig subclasses (7) and rendered 
specific by cross-absorption (8). Purified anti-Ig antibodies were raised as described elsewhere (9). 
ALLOANTISERA.  To  raise  hyperimmune  CBA  anti-C57BL  alloantiserum,  CBA/J  mice  were 
given five injections of 3  x  l0  T  C57BL spleen cells at fortnightly intervals and bled 2 wk after the 
last injection. This serum killed >95% of (CBA/J ×  C57BL)F~ lymph node cells in the presence of 
guinea pig complement. 
"Early" CBA anti-C57BL alloantiserum was prepared by injecting CBA/J mice with 2  ×  108 
(CBA/J  ×  C57BL)FI  spleen  cells  and bleeding the recipients 5,  6,  or  7  days  later.  To  remove 
activity against public H-2 specificities present on DBA/2 cells, the sera were absorbed extensively 
with DBA/2 spleen cells before use. Similarly, early CBA anti-DBA/2 serum was raised in CBA/J 
mice injected with (CBA/J x  DBA/2)FI spleen cells and the antiserum absorbed with C57BL spleen 
cells. 
Incubation of T.TDL in sera,  Aliquots of 107 T.TDL were incubated (30 min at 37°C)  in a  1:4 
dilution of the relevant antiserum containing 20 mM sodium azide and washed three times by 
centrifugation before immunofiuorescent staining (4). 
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TABLE I 
Percentage  of lmmunoglobulin-Positive Cells in T.TDL Activated either to H-2 
Determinants or M Locus Determinants: Cells Collected from Lymph at 4-5 days after 
Thymus Cell Transfer 
X-irradiated recipi-  Activating de-  Transferred* cells  ents  terminants 
% Fluorescent  T.TDL with* 
Anti-Ig anti- 
bodies  Anti-IgM  Anti-IgGl 
Normal CBA/J thymus  (CBA/J  ×  C57BL)FL  ~  59 ±  21 (14)  34 ±  6 (6)  4  ±  2 (6) 
B-depleted CBA/J thymus  (CBA/J ×  C57BL)F~  ~  H-2 b +  Mls  b  7 ±  8 (10)  2  ±  2 (6)  6  ±  4 (3) 
B-depleted CBA/J thymus  (CBA/J  ×  C57BL)F1  69  24  4 
+  TxBM CBA/J 
lymph node§ 
Normal CBA/J thymus  (CBA/J  ×  DBA/2)F~  t  H'2d +  Mlsa  75  ND[I  ND 
B-depleted CBA/J thymus  (CBA/J  ×  DBA/2)F]  7  ND  ND 
Normal C3H/J thymus  CBA/J  Mls  d  7  ±  7 (6)  0.9  3 
Normal BALB/c thymus  DBA/2  Mls  a  5  ±  6 (3)  2.5  6 
* 2  ×  l0  s cells transferred intravenously into X-irradiated (800 R) mice. 
§ 2  ×  104 cells from thymectomized, irradiated bone marrow reconstituted mice. Cytotoxic index with AKR/J 
anti-SC3H serum and complement (10) was <3%; this antiserum lysed >75% of lymph node cells prepared from 
normal mice. 
* Data as mean ±  SD.  Number of observations in parenthesis, or mean of two experiments. 
II ND, not determined. 
Results 
Surface  Ig,  as  detected  by  indirect  immunofluorescence,  was  present  on 
approximately 60% of T.TDL obtained from irradiated (CBA/J x  C57BL)F~ mice 
injected  4-5  days  previously with  CBA/J  thymus  cells  (Table  I).  A  similar 
proportion  of DBA/2-activated  CBA/J T.TDL were Ig positive.  When  stained 
cells were incubated at 37°C before counting, over 90% of the blast cells showed 
immunofluorescent  caps,  suggesting  that  all  the blast cells probably carried 
small amounts of surface Ig. Removal of B cells from the thymocyte progenitors 
caused up to a  10-fold reduction in the number of Ig-positive T.TDL (Table I). 
This  reduction was not observed when the  B-cell-depleted thymus cells were 
injected together with 2 x  106 B cells (lymph node cells from TxBM CBA/J mice). 
Table I also shows that T.TDL raised between strains differing only at the M 
locus contained very few Ig-positive cells; this applied both with CBA/J (Mlsd)-ac  - 
tivated C3H/J T.TDL and DBA/2 (Mlsa)-activated BALB/c T.TDL. 
When the activated cells were collected at 5-6 days, both H-2-activated and 
M-locus-activated T.TDL  contained  a  high  proportion  (40-50%)  of Ig-positive 
cells (Table II). Staining  with subclass-specific antisera  showed that the Ig on 
the M-locus-activated cells was almost entirely IgG (IgG~ and IgG2a, though not 
IgG2b). On H-2-activated T.TDL, however, the surface Ig consisted of a mixture 
of IgM and IgG. 
To investigate whether H-2-activated T.TDL could bind alloantibody in vitro, 
C57BL-activated CBA]J T.TDL derived from B-cell-depleted thymus cells were 
incubated  in  vitro  with  either  normal  mouse  (CBA/J)  serum,  hyperimmune 
CBA/J anti-C57BL antiserum,  or "early bleed" CBA/J anti-C57BL antiserum; 446  HUDSON  AND  SPRENT  BRIEF  DEFINITIVE  REPORT 
TABLE  II 
Class Distribution of  lmmunoglobulin on T.TDL Activated either to H-2 Determinants or M- 
Locus Determinants: Cells Collected from Lymph at 5-6 days after Thymus Cell Transfer 
% Positive  T-TDL aRet  incubation in  antiserum  to: 
X-irradiated  Ig (purl- 
Transferred cells*  recipients  IgM  IgA  IgG1  IgG2a  IgGzb  NRIgG$  fled anti- 
body [9]) 
CBA/Jthymus  (CBA/J ×  40.0±27  2.8  ±  2.9  48  ±  5.7  21  ±  11  8.5  ±  2.5  6.5  ±  2.4  56 ±  8.2§ 
C57BL)F~ 
CBA/J thymus, B-cell  (CBA/J ×  5.0  ND~  26  ND  ND  4.1  29 
depleted  C57BL)F~ 
C3H/Jthymus  CBA/J  1.8 ± 0.8  0.3-+ 0.3  38  ±  3.7  46 ±  20  2.9-+  0.1  4.1  ±  0.2  41  ±  3.0 
* 2 x 108  cells  transferred  intravenously. 
~t  NRIgG, normal rabbit  IgG; ND, not  determined. 
§ Data as  mean ± SD. Where SD is  shown, mean of  four  observations,  otherwise mean of  two  observations. 
TABLE  Ill 
Capacity  of  (a  )  H-2-Activated  T.TDL Derived  from  B-Cell-Depleted  Thymus and (b  )  M- 
Locus-Activated  T.TDL to  Adsorb  IgM and  IgG~  from  Alloantisera  and  Normal Serum 
In Vitro 
T.TDL incubated at  37°C for  30 rain  in: 
T.TDL 
CBA/J anti-C57BL  C3H/J anti-CBA/J 
% Stained with*:  % Stained  with*: 
Anti-  Anti-  Anti-  Anti- 
IgM  IgG~  IgM  IgG~ 
1:4 dilution, 5 day CBA anti-C57BL serums 
1:4 dilution, 6 day CBA anti-C57BL serum 
1:4 dilution, 7 day CBA anti-C57BL serum 
1:4 dilution, hyperimmune CBA anti-C57BL serums 
1:4 dilution, normal CBA serum 
1:4 dilution, 7 day CBA anti-DBA/2 serum$ 
Medium alone, at 4°C 
32  23  4  37 
36  29  9  20 
4  34  4  29 
4  21  7  13 
7  26  1  34 
2  21  0  46 
2  5  0  3 
* By indirect immunofluorescence T.TDL collected at 4-5 days after thymus injection. 
S Antisera raised as described in Materials and Methods. 
the latter was obtained at 5, 6, or 7 days after initial sensitization, i.e., at a stage 
when most of the antibody would presumably be IgM (see Materials and Meth- 
ods). 
T.TDL bound IgG (IgG1)  irrespective  of  the serum used for incubation (Table 
III).  Uptake of  IgM, however, was only  observed with  the early  bleed antirecipi- 
ent antiserum and then only when the latter  was obtained at 5 or 6 days 
postsensitization.  Uptake oflgM from these  antisera  was either  very low (Table 
III) or absent  (Table IV) with M-locus-activated (CBA/J-activated) C3H/J 
T.TDL. 
The specificity  of  the uptake of  IgM by T.TDL is shown in Table IV. C57BL- 
activated CBA/J T.TDL bound IgM when incubated with 6-day bleed CBA/J 
anti-C57BL antiserum but not with CBA/J anti-DBA/2 serum. Reciprocal re- 
sults were obtained with DBA/2-activated  CBA/J T.TDL. M-locus-activated 
T.TDL did not adsorb IgM from either antiserum. Again, IgG was adsorbed 
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TABLE  IV 
Specificity  of In Vitro Uptake of lgM and lgGl onto T.TDL 
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T.TDL*  Activating deter-  T.TDL incubated at 37°C for 
minants  30 rain in 1:4 dilution of: 
% Stained with: 
Anti-IgM  Anti-IgG~ 
CBA/J anti-DBA/2  H-2  d +  Mls  a 
CBA/J anti-C57BL  H-2  b +  Mls  ~ 
C3H/J anti-CBA/J  Mls d 
CBA anti-C57BL serum  2  77 
CBA anti-DBA/2 serum  33  41 
Medium alone  3  3 
CBA anti-C57BL serum  13  40 
CBA anti-DBA/2 serum  1  43 
Medium alone  2  3 
CBA anti-C57BL serum  3  30 
CBA anti-DBA/2 serum  3  49 
Medium alone  2  5 
* T.TDL derived from B-cell-depleted thymus; cells collected day 4-5. 
Discussion 
The present paper presents three pieces of  evidence  which support the hypothe- 
sis that the IgM detected by indirect immunofluorescence  on T.TDL represents 
specific alloantibody of donor B-cell  origin.  First,  IgM was present on H-2- 
activated T.TDL derived from normal thymus (Table I)  or lymph node cells 
(unpublished data), but not when these cells were depleted of B cells before 
injection (Table I); this deficit of IgM-positive T.TDL was not observed when the 
B-cell-depleted precursors were supplemented with small numbers of B cells. 
Second, surface IgM was not detected on T.TDL raised between strains differing 
only at the M-locus (Tables I and II).  Third, H-2-activated T.TDL bound IgM 
specifically  when incubated with antirecipient (but not antithird-party) alloanti- 
sera in vitro (Tables III and IV); this was only observed with sera obtained soon 
after initial sensitization, i.e., at a time when the alloantibodies were presum- 
ably IgM rather than IgG. 
It was suggested previously that specific IgM antibody on T.TDL is attached 
to antigen-specific receptors on the cells via a bridge of soluble host alloantigen 
(4). How then can one explain the capacity of IgM-negative H-2-activated T.TDL 
(i.e., T.TDL derived from B-cell-depleted T cells)  to adsorb IgM from specific 
alloantisera in vitro? There would appear to be two main possibilities. First, the 
IgM adsorbed from the alloantisera might have been in the form of immune 
complexes; in  this  situation  the  complexes could  become  attached (via  the 
antigen) to alloantigen-specific receptors on the cells.  Second, the IgM could 
have been free antibody which attached to cells carrying  receptor-bound  alloanti- 
gens not complexed with antibody. We cannot at present distinguish between 
these two possibilities. Nevertheless, it is intriguing to consider that if  the second 
possibility were correct, i.e. the specific receptors on the cells were blocked, it 
might explain why T.TDL enter the lymph of the host rather than remaining 
sequestered in the alloantigen-rich environment of the lymphoid tissues. 
Preliminary experiments have shown that large numbers of T.TDL can be 
generated between strains differing only at the I  region of the H-2 complex (J. 
Sprent, L. Hudson, M. Nabholz, and H. yon Boehmer, unpublished data). When 
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were Ig positive. This was not observed, however when the T.TDL were derived 
from B-cell-depleted lymph node cells.  Hence much of the  specific antibody 
detected on T.TDL could represent anti-/-region (anti-Ia) antibody complexed to 
host-type Ia antigens. 
Much of the IgG detected on T.TDL appeared to bind nonspecifically. With 
both H-2-activated and M-locus activated populations, the cells carried surface 
IgG when collected from the lymph at day 5-6 but not at day 4-5.  The cells 
collected at day 4-5,  however, were able to bind IgG when incubated with 
normal mouse serum (and other sera) in vitro. There are several reports that at 
least certain T-cell populations express Fc receptors (FcR) for IgG (e.g. 11, 12). It 
could be argued therefore that T.TDL express FcR which are of very low affinity 
when collected at day 4-5 but of higher affinity at day 5-6. The adsorption of  IgG 
from normal mouse serum in vitro by the day 4-5 cells was only observed with 
relatively high concentration (1:4 dilution) of serum (Table HI, and unpublished 
data); such conditions might be optimal for detecting FcR of low affinity. It is 
nevertheless puzzling that T.TDL collected at this stage failed to adsorb IgG 
from the lymph, the concentration of IgG in lymph being, at least in rats (13), 
only three- to four-fold lower than in serum. Even more puzzling, however, is 
the  failure of our own and other groups  to  demonstrate FcR on  T.TDL by 
conventional (14, 15)  techniques.  Further investigation will be  necessary to 
resolve this paradox. 
Since in the case of the day 5-6 H-2-activated T.TDL the numbers of IgG- 
positive cells were partly reduced when the precursors were depleted of B cells 
(Table  II),  some of the  IgG detected on  the  cells might have been  specific 
antibody. Although it is unlikely that this accounted for the IgG on M-locus- 
activated T.TDL, this possibility has yet to be excluded. 
It was suggested previously that FcR might stabilize the binding of specific 
IgM antibody to T.TDL (4). Although in the present study we failed to demon- 
strate nonspecific uptake of IgM by T.TDL, the cells might express FcR of low 
avidity for IgM. The recent report that thymus cells express FcR for IgM after 
culture in vitro (16) is at least consistent with this view. 
Summary 
Evidence is presented to support the contention that IgM demonstrable by 
surface immunofluorescent  staining on H-2-activated T cells represents specifi- 
cally adsorbed B-cell-derived alloantibody. T cells activated to H-2 determinants 
expressed surface IgM only when the progenitor cell populations contained B 
lymphocytes. IgM was not detected on T cells activated to determinants which 
fail to stimulate alloantibody production (e.g., M-locus determinants). In addi- 
tion, IgM-negative H-2-activated T cells (derived from B-cell-depleted lymphoid 
cells), unlike M-locus-activated  T cells, adsorbed IgM in a specific manner when 
incubated in vitro with "early bleed" antisera raised against the activating H-2 
determinants. 
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